In summary, we present a new bacterium-based therapeutic strategy with BGs that produced high-quality EcN ghosts on a large scale and sequentially expressed the Lpp-OmpA-ATRAM for selective cancer cell therapy. This evidence concerns the gene LPP and cancer.